Search / Trial NCT06229951

Hydrolyzed Collagen and Undenatured Collagen Type II in OA Knee

Launched by PRINCE OF SONGKLA UNIVERSITY · Jan 25, 2024

Trial Information

Current as of December 22, 2024

Not yet recruiting

Keywords

Osteoarthritis Collagen Supplement

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: 50-80 years old
  • Medial compartment knee osteoarthritis
  • Kellgren and Lawrence classification stage 2 -3
  • Able to walk without walking aid
  • Exclusion Criteria:
  • History of knee surgery on the study side
  • History of intra-articular steroid injection within 6 months prior to study entry
  • Systemic arthritis conditions
  • Degenerative neurological and muscular conditions in the lower extremities
  • Chronic kidney disease with CrCl \< 30 ml/min

About Prince Of Songkla University

Prince of Songkla University (PSU) is a prestigious academic institution located in Thailand, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, PSU leverages its extensive resources and expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among multidisciplinary teams of researchers, healthcare professionals, and students, ensuring rigorous study designs and adherence to ethical standards. PSU's dedication to improving public health outcomes is reflected in its focus on translating research findings into practical applications that benefit local and global communities.

Locations

Hat Yai, Songkhla, Thailand

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0